Filing Details

Accession Number:
0001062993-23-015886
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-04 20:22:09
Reporting Period:
2022-08-31
Accepted Time:
2023-08-04 20:22:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607962 Rewalk Robotics Ltd. RWLK Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1877823 Jeannine Lynch C/O Rewalk Robotics Ltd.
3 Hatnufa St., P.o. Box 161
Yokneam Ilit L3 20692203
Vp Of Market Access & Strategy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Nis 0.25 Per Share Disposition 2022-08-31 9,692 $0.98 390,308 No 4 S Indirect ESOP
Ordinary Shares, Par Value Nis 0.25 Per Share Disposition 2023-08-02 10,476 $0.69 379,832 No 4 S Indirect ESOP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect ESOP
No 4 S Indirect ESOP
Footnotes
  1. This transaction is being filed late due to an administrative error.
  2. Represents Ordinary Shares sold in the open market on August 31, 2022, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 31, 2022, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on August 31, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
  3. Represents Ordinary Shares sold in the open market on August 2, 2023, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 2, 2023, of certain RSUs previously granted to the Reporting Person under the Plan on August 2, 2022. The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and the Company and does not represent a discretionary trade by the Reporting Person.
  4. Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $0.68 to $0.7103. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.